Parvaquone
Therapeutic Category:
Antiprotozoal
Interferes with protozoal mitochondrial respiration; coccidiostatic
Primary Use:
Equine protozoal myeloencephalitis (EPM); off-label in other species
Sarcocystis, Neospora, Toxoplasma
Target Species:
Horses; off-label in dogs and cats
Status:
Commercial
Monograph:
In House
Regulatory Status:
DMF
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.